The authors of the new meta-analysis aimed to provide an update on the association between ankylosing spondylitis and cancer incidence. “While the etiology of ankylosing spondylitis remains elusive, ...

Ivarmacitinib, a highly selective Janus kinase 1 (JAK1) inhibitor, tamed ankylosing spondylitis with sustained efficacy through 24 weeks in a phase 2/3 trial. A phase 2/3 trial in China evaluated the ...

Ankylosing spondylitis (AS), also called axial spondyloarthritis, can cause stiffness in the neck and shoulders. Neck and shoulder pain might get worse after lying or sitting for a time, causing ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...

Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ...

Ankylosing spondylitis affects women more often than previously thought. In the past, AS was believed to more commonly affect men, but newer research suggests the rates may be nearly equal between the ...